FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765586743> ?p ?o ?g. }

• W2765586743 endingPage "130" @default.
• W2765586743 startingPage "118" @default.
• W2765586743 abstract "Although trastuzumab provides significant clinical benefit for HER2-positive breast cancers, responses are limited by the emergence of resistance. Trastuzumab resistance is a multi-factorial phenomenon thought to arise from the presence of cancer stem cells and interactions between truncated p95HER2 and HER family members. Flubendazole (FLU) is a potent anthelmintic agent with an exceptional safety profile. Evidence also suggests that it can act as an anticancer agent in several cancer cell types. We sought to investigate the effect of FLU on apoptosis, HER2/Akt signaling, breast cancer stem cell (BCSC)-like properties and trastuzumab resistance in HER2-positive breast cancer cells. FLU treatment induced apoptosis, associated with a significant downregulation of truncated p95HER2, phospho-HER2, phospho-HER3 and phospho-Akt levels, as well as suppression of HER2/HER3 hetero-dimerization in both trastuzumab-sensitive and –resistant lines. FLU effectively targeted BCSC-like properties including aldehyde dehydrogenase 1 (ALDH1) expression and the CD44high/CD24low phenotype, concomitant with a suppression of mammosphere-forming ability. FLU administration also caused significant tumor suppression in trastuzumab-resistant xenografts, coinciding with the downregulation of BCSC-related markers and intracellular HER2. These findings highlight the mechanisms of action of FLU in overcoming trastuzumab resistance in breast cancer." @default.
• W2765586743 created "2017-11-10" @default.
• W2765586743 creator A5015236484 @default.
• W2765586743 creator A5015389392 @default.
• W2765586743 creator A5016426539 @default.
• W2765586743 creator A5021861062 @default.
• W2765586743 creator A5039735987 @default.
• W2765586743 creator A5053684584 @default.
• W2765586743 creator A5059390322 @default.
• W2765586743 creator A5075425803 @default.
• W2765586743 date "2018-01-01" @default.
• W2765586743 modified "2023-10-17" @default.
• W2765586743 title "Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer" @default.
• W2765586743 cites W1623594020 @default.
• W2765586743 cites W1654551777 @default.
• W2765586743 cites W1756841812 @default.
• W2765586743 cites W1895627253 @default.
• W2765586743 cites W1928089056 @default.
• W2765586743 cites W1964321121 @default.
• W2765586743 cites W1971579914 @default.
• W2765586743 cites W1976203623 @default.
• W2765586743 cites W2010412413 @default.
• W2765586743 cites W2012204343 @default.
• W2765586743 cites W2023316892 @default.
• W2765586743 cites W2023427658 @default.
• W2765586743 cites W2023681515 @default.
• W2765586743 cites W2026379260 @default.
• W2765586743 cites W2035880310 @default.
• W2765586743 cites W2037769103 @default.
• W2765586743 cites W2039609199 @default.
• W2765586743 cites W2056579307 @default.
• W2765586743 cites W2062069198 @default.
• W2765586743 cites W2068071851 @default.
• W2765586743 cites W2069439128 @default.
• W2765586743 cites W2069526613 @default.
• W2765586743 cites W2074347542 @default.
• W2765586743 cites W2076797981 @default.
• W2765586743 cites W2085665189 @default.
• W2765586743 cites W2097308038 @default.
• W2765586743 cites W2099365945 @default.
• W2765586743 cites W2100608628 @default.
• W2765586743 cites W2101299592 @default.
• W2765586743 cites W2101824720 @default.
• W2765586743 cites W2104337757 @default.
• W2765586743 cites W2107426197 @default.
• W2765586743 cites W2109439031 @default.
• W2765586743 cites W2116424772 @default.
• W2765586743 cites W2119774495 @default.
• W2765586743 cites W2123206362 @default.
• W2765586743 cites W2127617517 @default.
• W2765586743 cites W2129816567 @default.
• W2765586743 cites W2137771360 @default.
• W2765586743 cites W2139135964 @default.
• W2765586743 cites W2139444209 @default.
• W2765586743 cites W2141393790 @default.
• W2765586743 cites W2149908785 @default.
• W2765586743 cites W2154834163 @default.
• W2765586743 cites W2159640574 @default.
• W2765586743 cites W2159789252 @default.
• W2765586743 cites W2163292580 @default.
• W2765586743 cites W2169344919 @default.
• W2765586743 cites W2170241131 @default.
• W2765586743 cites W2172118845 @default.
• W2765586743 cites W2172265576 @default.
• W2765586743 cites W2213952892 @default.
• W2765586743 cites W2223581935 @default.
• W2765586743 cites W2295953618 @default.
• W2765586743 cites W2318605753 @default.
• W2765586743 cites W2405004189 @default.
• W2765586743 cites W2435000139 @default.
• W2765586743 cites W2556607291 @default.
• W2765586743 cites W2604207380 @default.
• W2765586743 cites W2612336386 @default.
• W2765586743 doi "https://doi.org/10.1016/j.canlet.2017.10.020" @default.
• W2765586743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29080749" @default.
• W2765586743 hasPublicationYear "2018" @default.
• W2765586743 type Work @default.
• W2765586743 sameAs 2765586743 @default.
• W2765586743 citedByCount "40" @default.
• W2765586743 countsByYear W27655867432018 @default.
• W2765586743 countsByYear W27655867432019 @default.
• W2765586743 countsByYear W27655867432020 @default.
• W2765586743 countsByYear W27655867432021 @default.
• W2765586743 countsByYear W27655867432022 @default.
• W2765586743 countsByYear W27655867432023 @default.
• W2765586743 crossrefType "journal-article" @default.
• W2765586743 hasAuthorship W2765586743A5015236484 @default.
• W2765586743 hasAuthorship W2765586743A5015389392 @default.
• W2765586743 hasAuthorship W2765586743A5016426539 @default.
• W2765586743 hasAuthorship W2765586743A5021861062 @default.
• W2765586743 hasAuthorship W2765586743A5039735987 @default.
• W2765586743 hasAuthorship W2765586743A5053684584 @default.
• W2765586743 hasAuthorship W2765586743A5059390322 @default.
• W2765586743 hasAuthorship W2765586743A5075425803 @default.
• W2765586743 hasConcept C104317684 @default.
• W2765586743 hasConcept C121608353 @default.
• W2765586743 hasConcept C126322002 @default.
• W2765586743 hasConcept C127561419 @default.

• next